CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Cash flows from operating activities:
Net cash provided by operating activities	$ 927,809	$ 1,020,957
Cash flows from investing activities:
Capital expenditures	(162,726)	(139,054)
Origination of finance receivables	(3,009,479)	(3,112,827)
Collections on finance receivables	2,440,466	2,393,355
Proceeds from finance receivables sold	312,571	0
Sales and redemptions of marketable securities	40,014	9,500
Payments to Acquire Businesses and Interest in Affiliates	0	59,910
Other	251	5,172
Net cash used by investing activities	(378,903)	(903,764)
Cash flows from financing activities:
Proceeds from Issuance of Unsecured Debt	0	740,949
Proceeds from issuance of medium-term notes	1,193,396	595,386
Repayments of medium-term notes	(451,336)	(600,000)
Proceeds from securitization debt	0	1,195,668
Repayments of securitization debt	(535,616)	(764,909)
Net (decrease) increase in credit facilities and unsecured commercial paper	(146,328)	258,734
Borrowings of asset-backed commercial paper	33,428	69,191
Repayments of asset-backed commercial paper	(55,170)	(55,124)
Net change in restricted cash	30,981	(15,165)
Dividends paid	(190,387)	(191,451)
Purchase of common stock for treasury	(374,234)	(894,565)
Excess tax benefits from share-based payments	1,291	2,878
Issuance of common stock under employee stock option plans	6,444	16,755
Net cash (used by) provided by financing activities	(487,531)	358,347
Effect of exchange rate changes on cash and cash equivalents	6,700	(13,666)
Net increase (decrease) in cash and cash equivalents	68,075	461,874
Cash and cash equivalents:
Cash and cash equivalents—beginning of period	722,209	906,680
Net increase in cash and cash equivalents	68,075	461,874
Cash and cash equivalents—end of period	$ 790,284	$ 1,368,554